UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 11
November-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2511108


Registration ID:
571171

Page Number

b66-b70

Share This Article


Jetir RMS

Title

COMPARATIVE STUDY OF THE GENERIC DRUG APPROVAL PROCEDURE AND REGISTRATION IN EUROPE, THE UNITED STATES, AND INDIA IN COMPLIANCE WITH CTD

Abstract

In order to guarantee that the general population has access to safe and reasonably priced medications, the pharmaceutical sector is essential. Since generic pharmaceuticals are less expensive than branded ones, they must follow stringent legal requirements to ensure their quality, safety, and effectiveness.With an emphasis on the Common Technical Document (CTD) format, this comparative study examines the generic medicine approval procedure and registration requirements in Europe, the USA, and India. The study investigates the regulatory frameworks of the Central Drugs Standard Control Organization (CDSCO), the US Food and Drug Administration (USFDA), and the European Medicines Agency (EMA) in India. The dossier preparation procedure, bioequivalence analyses, filing schedules, and post-approval procedures are important factors. Highlighted are variations in administrative practices, harmonization initiatives under the International Council for Harmonization (ICH), and difficulties unique to each region. In the end, the results hope to improve patient access to reasonably priced healthcare solutions by offering guidance to pharmaceutical companies navigating the global regulatory environment and encouraging streamlined procedures for quicker generic medicine market launch. deadlines for filing and post-approval specifications.

Key Words

Generic drugs, Common Technical Document (CTD) format, Europe, the USA, and India, European Medicines Agency (EMA), the United States Food and Drug Administration (USFDA), and the Central Drugs Standard Control Organization (CDSCO).

Cite This Article

"COMPARATIVE STUDY OF THE GENERIC DRUG APPROVAL PROCEDURE AND REGISTRATION IN EUROPE, THE UNITED STATES, AND INDIA IN COMPLIANCE WITH CTD", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 11, page no.b66-b70, November-2025, Available :http://www.jetir.org/papers/JETIR2511108.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"COMPARATIVE STUDY OF THE GENERIC DRUG APPROVAL PROCEDURE AND REGISTRATION IN EUROPE, THE UNITED STATES, AND INDIA IN COMPLIANCE WITH CTD", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 11, page no. ppb66-b70, November-2025, Available at : http://www.jetir.org/papers/JETIR2511108.pdf

Publication Details

Published Paper ID: JETIR2511108
Registration ID: 571171
Published In: Volume 12 | Issue 11 | Year November-2025
DOI (Digital Object Identifier):
Page No: b66-b70
Country: Guntur, Andhra Pradesh, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00059

Print This Page

Current Call For Paper

Jetir RMS